Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 84 people, planned
- Started
- 13 Feb 2026
- Expected to end
- Jan 2028
- Type of study
- Interventional
- Treatments tested
- Nicotine pouch: Low dose
- Nicotine pouch: High dose
- Low pH
- High pH
- Record updated
- 27 February 2026
Who can take part
- Age
- 21 years to 35 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Current established users of nicotine pouches (have used nicotine pouches in the past 30 days \& currently use nicotine pouches every day or someday)
- Positive cotinine test via saliva test strip
- Those who are unmotivated to quit nicotine use
- Read and speak English
- Poly-users of nicotine pouches, e-cigarettes (e.g., vape ≥20 days/month), and tobacco (e.g., ≥4 cigarettes/day for ≥2 years) will be eligible for participation
Who cannot take part
- History of stroke, seizures, high blood pressure, heart disease/problems, or cardiovascular disease contraindications for nicotine
- Planning to cut down or quit using nicotine in the next 30 days
- Currently pregnant or breastfeeding
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 21 and 35 years old?
This trial is currently available in United States.
- Rollins School of Public HealthAtlanta, United StatesContact: Dae Hee Han, PhDTaking people
About the trial
What the trial wants to find out
The goal of this study is to assess the effects of nicotine concentration and its interplay with pH on sensory experience, product appeal, and abuse liability of NPs among young adults NP users.
Read full original descriptionShow less
Primary objective is to assess the effect of variation in nicotine concentration in nicotine pouches (NPs) and its interaction effect with pH level on three proximal outcomes of relevance to regulation: (1) sensory experience, (2) product appeal, and (3) abuse liability of NPs.
The group in the trial
- Nicotine Pouches groupTreatment being tested
Participants will self-administer NPs that differ along two experimental factors: nicotine concentration (low \[e.g., 3-4 mg\] vs. high \[e.g., 6-8 mg\]) and pH level (low \[\<8.5\] vs. high \[≥8.5\]). Each participant will be exposed to all four NP conditions in randomized order, with one condition administered per visit.
Treatment: Nicotine pouch: Low dose, Nicotine pouch: High dose, Low pH, and High pH
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07165808, who can take part
- Record updated
- 27 February 2026